SEARCH

SEARCH BY CITATION

References

  • Abidi F. E., Holinski-Feder E., Rittinger O., Kooy F., Lubs H. A., Stevenson R. E. and Schwartz C. E. (2002) A novel 2 bp deletion in the TM4SF2 gene is associated with MRX58. J. Med. Genet. 39, 430433.
  • Akbarian S. and Huang H. S. (2006) Molecular and cellular mechanisms of altered GAD1/GAD67 expression in schizophrenia and related disorders. Brain Res. Rev. 52, 293304.
  • Akbarian S., Kim J. J., Potkin S. G., Hagman J. O., Tafazzoli A., Bunney W. E. Jr and Jones E. G. (1995) Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch. Gen. Psychiatry 52, 258266.
  • Alvarez V. A. and Sabatini B. L. (2007) Anatomical and physiological plasticity of dendritic spines. Annu. Rev. Neurosci. 30, 7997.
  • Andersson R. H., Johnston A., Herman P. A., Winzer-Serhan U. H., Karavanova I., Vullhorst D., Fisahn A. and Buonanno A. (2012) Neuregulin and dopamine modulation of hippocampal gamma oscillations is dependent on dopamine D4 receptors. Proc. Natl Acad. Sci. USA 109, 1311813123.
  • Arango C., Moreno C., Martínez S., Parellada M., Desco M., Moreno D., Fraguas D., Gogtay N., James A. and Rapoport J. (2008) Longitudinal brain changes in early-onset psychosis. Schizophr. Bull. 34, 341353.
  • Ayhan Y., Abazyan B. and Nomura J. et al. (2011) Differential effects of prenatal and postnatal expressions of mutant human DISC1 on neurobehavioral phenotypes in transgenic mice: evidence for neurodevelopmental origin of major psychiatric disorders. Mol. Psychiatry 16, 293306.
  • Bacanu S. A., Devlin B., Chowdari K. V., DeKosky S. T., Nimgaonkar V. L. and Sweet R. A. (2005) Heritability of psychosis in Alzheimer disease. Am. J. Geriatr. Psychiatry 13, 624627.
  • Baloyannis S. J., Costa V., Mauroudis I., Psaroulis D., Manolides S. L. and Manolides L. S. (2007) Dendritic and spinal pathology in the acoustic cortex in Alzheimer's disease: morphological and morphometric estimation by Golgi technique and electron microscopy. Acta Otolaryngol. 127, 351354.
  • Barros C. S., Calabrese B., Chamero P., Roberts A. J., Korzus E., Lloyd K., Stowers L., Mayford M., Halpain S. and Müller U. (2009) Impaired maturation of dendritic spines without disorganization of cortical cell layers in mice lacking NRG1/ErbB signaling in the central nervous system. Proc. Natl Acad. Sci. USA 106, 45074512.
  • Barta P. E., Pearlson G. D., Powers R. E., Richards S. S. and Tune L. E. (1990) Auditory hallucinations and smaller superior temporal gyral volume in schizophrenia. Am. J. Psychiatry 147, 14571462.
  • Bartos M., Vida I. and Jonas P. (2007) Synaptic mechanisms of synchronized gamma oscillations in inhibitory interneuron networks. Nat. Rev. Neurosci. 8, 4556.
  • Bassani S., Cingolani L. A., Valnegri P., Folci A., Zapata J., Gianfelice A., Sala C., Goda Y. and Passafaro M. (2012) The X-Linked Intellectual Disability Protein TSPAN7 Regulates Excitatory Synapse Development and AMPAR Trafficking. Neuron 73, 11431158.
  • Bean B. P. (2007) The action potential in mammalian central neurons. Nat. Rev. Neurosci. 8, 451465.
  • Belforte J. E., Zsiros V., Sklar E. R., Jiang Z., Yu G., Li Y., Quinlan E. M. and Nakazawa K. (2010) Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes. Nat. Neurosci. 13, 7683.
  • Bergeron R. and Coyle J. T. (2012) NAAG, NMDA receptor and psychosis. Curr. Med. Chem. 19, 13601364.
  • Berkel S., Marshall C. R., Weiss B. et al. (2010) Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardation. Nat. Genet. 42, 489491.
  • Bhat S. S., Ladd S., Grass F., Spence J. E., Brasington C. K., Simensen R. J., Schwartz C. E., Dupont B. R., Stevenson R. E. and Srivastava A. K. (2008) Disruption of the IL1RAPL1 gene associated with a pericentromeric inversion of the X chromosome in a patient with mental retardation and autism. Clin. Genet. 73, 9496.
  • Bhat S., Dao D. T., Terrillion C. E., Arad M., Smith R. J., Soldatov N. M. and Gould T. D. (2012) CACNA1C (Ca(v)1.2) in the pathophysiology of psychiatric disease. Prog. Neurobiol. 99, 114.
  • Bittner T., Fuhrmann M., Burgold S., Ochs S. M., Hoffmann N., Mitteregger G., Kretzschmar H., LaFerla F. M. and Herms J. (2010) Multiple events lead to dendritic spine loss in triple transgenic Alzheimer's disease mice. PLoS ONE 5, e15477.
  • Bockers T. M., Segger-Junius M., Iglauer P., Bockmann J., Gundelfinger E. D., Kreutz M. R., Richter D., Kindler S. and Kreienkamp H. J. (2004) Differential expression and dendritic transcript localization of Shank family members: identification of a dendritic targeting element in the 3′ untranslated region of Shank1 mRNA. Mol. Cell. Neurosci. 26, 182190.
  • Bonaglia M. C., Giorda R., Borgatti R., Felisari G., Gagliardi C., Selicorni A. and Zuffardi O. (2001) Disruption of the ProSAP2 gene in a t(12;22)(q24.1;q13.3) is associated with the 22q13.3 deletion syndrome. Am. J. Hum. Genet. 69, 261268.
  • Bozdagi O., Sakurai T., Papapetrou D. et al. (2010) Haploinsufficiency of the autism-associated Shank3 gene leads to deficits in synaptic function, social interaction, and social communication. Mol. Autism 1, 15.
  • Bruen P. D., McGeown W. J., Shanks M. F. and Venneri A. (2008) Neuroanatomical correlates of neuropsychiatric symptoms in Alzheimer's disease. Brain 131, 24552463.
  • Buonanno A. (2010) The neuregulin signaling pathway and schizophrenia: from genes to synapses and neural circuits. Brain Res. Bull. 83, 122131.
  • Buonanno A. and Fischbach G. D. (2001) Neuregulin and ErbB receptor signaling pathways in the nervous system. Curr. Opin. Neurobiol. 11, 287296.
  • Burbach J. P. and van der Zwaag B. (2009) Contact in the genetics of autism and schizophrenia. Trends Neurosci. 32, 6972.
  • Cahill M. E., Xie Z., Day M. et al. (2009) Kalirin regulates cortical spine morphogenesis and disease-related behavioral phenotypes. Proc. Natl Acad. Sci. USA 106, 1305813063.
  • Carrie A., Jun L., Bienvenu T. et al. (1999) A new member of the IL-1 receptor family highly expressed in hippocampus and involved in X-linked mental retardation. Nat. Genet. 23, 2531.
  • Casamassima F., Hay A. C., Benedetti A., Lattanzi L., Cassano G. B. and Perlis R. H. (2010) L-type calcium channels and psychiatric disorders: A brief review. Am. J. Med. Genet. B Neuropsychiatr. Genet. 153B, 13731390.
  • Chattopadhyaya B. and Cristo G. D. (2012) GABAergic circuit dysfunctions in neurodevelopmental disorders. Front. Psychiatry 3, 51.
  • Chen Y. J., Johnson M. A., Lieberman M. D. et al. (2008) Type III neuregulin-1 is required for normal sensorimotor gating, memory-related behaviors, and corticostriatal circuit components. J. Neurosci. 28, 68726883.
  • Chen Y., Hancock M. L., Role L. W. and Talmage D. A. (2010) Intramembranous valine linked to schizophrenia is required for neuregulin 1 regulation of the morphological development of cortical neurons. J. Neurosci. 30, 91999208.
  • Chu S. H., Roeder K., Ferrell R. E., Devlin B., DeMichele-Sweet M. A., Kamboh M. I., Lopez O. L. and Sweet R. A. (2011) TOMM40 poly-T repeat lengths, age of onset and psychosis risk in Alzheimer disease. Neurobiol. Aging 32, 23282329.
  • Cobb S. R., Buhl E. H., Halasy K., Paulsen O. and Somogyi P. (1995) Synchronization of neuronal activity in hippocampus by individual GABAergic interneurons. Nature 378, 7578.
  • Collins A. L., Ma D., Whitehead P. L. et al. (2006) Investigation of autism and GABA receptor subunit genes in multiple ethnic groups. Neurogenetics 7, 167174.
  • Dean B., Keriakous D., Scarr E. and Thomas E. A. (2007) Gene expression profiling in Brodmann's area 46 from subjects with schizophrenia. Aust. N. Z. J. Psychiatry 41, 308320.
  • Delahaye A., Toutain A., Aboura A., Dupont C., Tabet A. C., Benzacken B., Elion J., Verloes A., Pipiras E. and Drunat S. (2009) Chromosome 22q13.3 deletion syndrome with a de novo interstitial 22q13.3 cryptic deletion disrupting SHANK3. Eur. J. Med. Genet. 52, 328332.
  • DeMichele-Sweet M. A., Lopez O. L. and Sweet R. A. (2011a) Psychosis in Alzheimer's disease in the national Alzheimer's disease coordinating center uniform data set: clinical correlates and association with apolipoprotein e1. Int. J. Alzheimers Dis. 2011, 926597.
  • DeMichele-Sweet M. A., Klei L., Devlin B., Ferrell R. E., Weamer E. A., Emanuel J. E., Lopez O. L. and Sweet R. A. (2011b) No association of psychosis in Alzheimer disease with neurodegenerative pathway genes. Neurobiol. Aging 32, 555.e9555.e11.
  • Demiralp T., Herrmann C. S., Erdal M. E., Ergenoglu T., Keskin Y. H., Ergen M. and Beydagi H. (2007) DRD4 and DAT1 Polymorphisms Modulate Human Gamma Band Responses. Cereb. Cortex 17, 10071019.
  • Deo A. J., Cahill M. E., Li S. et al. (2011) Increased expression of Kalirin-9 in the auditory cortex of schizophrenia subjects: Its role in dendritic pathology. Neurobiol. Dis. 45, 796803.
  • DiMaio S., Grizenko N. and Joober R. (2003) Dopamine genes and attention-deficit hyperactivity disorder: a review. J. Psychiatry Neurosci. 28, 2738.
  • Durand C. M., Betancur C., Boeckers T. M. et al. (2007) Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat. Genet. 39, 2527.
  • Emanuel J. E., Lopez O. L., Houck P. R., Becker J. T., Weamer E. A., DeMichele-Sweet M. A., Kuller L. and Sweet R. A. (2011) Trajectory of cognitive decline as a predictor of psychosis in early Alzheimer disease in the cardiovascular health study. Am. J. Geriatr. Psychiatry 19, 160168.
  • Engel A. K. and Singer W. (2001) Temporal binding and the neural correlates of sensory awareness. Trends Cogn. Sci. 5, 1625.
  • Fatemi S. H., Halt A. R., Stary J. M., Kanodia R., Schulz S. C. and Realmuto G. R. (2002) Glutamic acid decarboxylase 65 and 67 kDa proteins are reduced in autistic parietal and cerebellar cortices. Biol. Psychiatry 52, 805810.
  • Fatemi S. H., Reutiman T. J., Folsom T. D. and Thuras P. D. (2009) GABA(A) receptor downregulation in brains of subjects with autism. J. Autism Dev. Disord. 39, 223230.
  • Fazzari P., Paternain A. V., Valiente M., Pla R., Luján R., Lloyd K., Lerma J., Marín O. and Rico B. (2010) Control of cortical GABA circuitry development by Nrg1 and ErbB4 signaling. Nature 464, 13761380.
  • Fetterolf F. and Foster K. A. (2011) Regulation of long-term plasticity induction by the channel and C-terminal domains of GluN2 subunits. Mol. Neurobiol. 44, 7182.
  • Fisahn A., Neddens J., Yan L. and Buonanno A. (2009) Neuregulin-1 modulates hippocampal gamma oscillations: implications for schizophrenia. Cereb. Cortex 19, 612618.
  • Fox I. J. and Kornblum H. I. (2005) Developmental profile of ErbB receptors in murine central nervous system: implications for functional interactions. J. Neurosci. Res. 79, 584597.
  • Franek K. J., Butler J., Johnson J. et al. (2011) Deletion of the immunoglobulin domain of IL1RAPL1 results in nonsyndromic X-linked intellectual disability associated with behavioral problems and mild dysmorphism. Am. J. Med. Genet. A 155A, 11091114.
  • Franke B., Neale B. M. and Faraone S. V. (2009) Genome-wide association studies in ADHD. Hum. Genet. 126, 1350.
  • Fuchs E. C., Zivkovic A. R., Cunningham M. O. et al. (2007) Recruitment of parvalbumin-positive interneurons determines hippocampal function and associated behavior. Neuron 53, 591604.
  • Gai X., Xie H. M., Perin J. C. et al. (2012) Rare structural variation of synapse and neurotransmission genes in autism. Mol. Psychiatry 17, 402411.
  • Garcia R. A., Vasudevan K. and Buonanno A. (2000) The neuregulin receptor ErbB-4 interacts with PDZ-containing proteins at neuronal synapses. Proc. Natl Acad. Sci. USA 97, 35963601.
  • Gasbarri A., Packard M. G., Campana E. and Pacitti C. (1994) Anterograde and retrograde tracing of projections from the ventral tegmental area to the hippocampal formation in the rat. Brain Res. Bull. 33, 445452.
  • Gasbarri A., Sulli A. and Packard M. G. (1997) The dopaminergic mesencephalic projections to the hippocampal formation in the rat. Prog. Neuropsychopharmacol. Biol. Psychiatry 21, 122.
  • Gauthier J., Spiegelman D., Piton A. et al. (2009) Novel de novo SHANK3 mutation in autistic patients. Am. J. Med. Genet. B Neuropsychiatr. Genet. 150B, 421424.
  • Gerecke K. M., Wyss J. M., Karavanova I., Buonanno A. and Carroll S. L. (2001) ErbB transmembrane tyrosine kinase receptors are differentially expressed throughout the adult rat central nervous system. J. Comp. Neurol. 433, 86100.
  • Gilman S. R., Iossifov I., Levy D., Ronemus M., Wigler M. and Vitkup D. (2011) Rare de novo variants associated with autism implicate a large functional network of genes involved in formation and function of synapses. Neuron 70, 898907.
  • Girirajan S. and Eichler E. E. (2010) Phenotypic variability and genetic susceptibility to genomic disorders. Hum. Mol. Genet. 19, R176R187.
  • Glantz L. A. and Lewis D. A. (2000) Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch. Gen. Psychiatry 57, 6573.
  • Gogolla N., Leblanc J. J., Quast K. B., Sudhof T. C., Fagiolini M. and Hensch T. K. (2009) Common circuit defect of excitatory-inhibitory balance in mouse models of autism. J. Neurodev. Disord. 1, 172181.
  • Gonzalez-Burgos G. and Lewis D. A. (2008) GABA neurons and the mechanisms of network oscillations: implications for understanding cortical dysfunction in schizophrenia. Schizophr. Bull. 34, 944961.
  • Gonzalez-Burgos G. and Lewis D. A. (2012) NMDA receptor hypofunction, parvalbumin-positive neurons, and cortical gamma oscillations in schizophrenia. Schizophr. Bull. 38, 950957.
  • Govek E. E., Newey S. E., Akerman C. J., Cross J. R., Van der Veken L. and Van Aelst L. (2004) The X-linked mental retardation protein oligophrenin-1 is required for dendritic spine morphogenesis. Nat. Neurosci. 7, 364372.
  • Govindaiah G., Wang Y. and Cox C. L. (2010) Dopamine enhances the excitability of somatosensory thalamocortical neurons. Neuroscience 170, 981991.
  • Greenwood T. A., Lazzeroni L. C., Murray S. S. et al. (2011) Analysis of 94 candidate genes and 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. Am. J. Psychiat. 168, 930946.
  • Greenwood T. A., Light G. A., Swerdlow N. R., Radant A. D. and Braff D. L. (2012) Association analysis of 94 candidate genes and schizophrenia-related endophenotypes. PLoS ONE 7, e29630.
  • Grutzendler J., Helmin K., Tsai J. and Gan W. B. (2007) Various dendritic abnormalities are associated with fibrillar amyloid deposits in Alzheimer's disease. Ann. N. Y. Acad. Sci. 1097, 3039.
  • Guilmatre A., Dubourg C., Mosca A. L. et al. (2009) Recurrent rearrangements in synaptic and neurodevelopmental genes and shared biologic pathways in schizophrenia, autism, and mental retardation. Arch. Gen. Psychiatry 66, 947956.
  • Guptill J. T., Booker A. B., Gibbs T. T., Kemper T. L., Bauman M. L. and Blatt G. J. (2007) [3H]-flunitrazepam-labeled benzodiazepine binding sites in the hippocampal formation in autism: a multiple concentration autoradiographic study. J. Autism Dev. Disord. 37, 911920.
  • Hall J., Whalley H. C., Job D. E. et al. (2006) A neuregulin 1 variant associated with abnormal cortical function and psychotic symptoms. Nat. Neurosci. 9, 14771478.
  • Harrison P. J. and Weinberger D. R. (2005) Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol. Psychiatry 10, 4068; image 45.
  • Hayashi-Takagi A., Takaki M., Graziane N. et al. (2010) Disrupted-in-Schizophrenia 1 (DISC1) regulates spines of the glutamate synapse via Rac1. Nat. Neurosci. 13, 327332.
  • Herrmann C. S. and Demiralp T. (2005) Human EEG gamma oscillations in neuropsychiatric disorders. Clin. Neurophysiol. 116, 27192733.
  • Hill J. J., Hashimoto T. and Lewis D. A. (2006) Molecular mechanisms contributing to dendritic spine alterations in the prefrontal cortex of subjects with schizophrenia. Mol. Psychiatry 11, 557566.
  • Hollingworth P., Hamshere M. L., Holmans P. A. et al. (2007) Increased familial risk and genomewide significant linkage for Alzheimer's disease with psychosis. Am. J. Med. Genet. B Neuropsychiatr. Genet. 144B, 841848.
  • Hollingworth P., Sweet R., Sims R. et al. (2011) Genome-wide association study of Alzheimer's disease with psychotic symptoms. Mol. Psychiatry 17, 13161327.
  • Holtmaat A. and Svoboda K. (2009) Experience-dependent structural synaptic plasticity in the mammalian brain. Nat. Rev. 10, 647658.
  • Hsieh H., Boehm J., Sato C., Iwatsubo T., Tomita T., Sisodia S. and Malinow R. (2006) AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss. Neuron 52, 831843.
  • Huang Y. Z., Won S., Ali D. W. et al. (2000) Regulation of neuregulin signaling by PSD-95 interacting with ErbB4 at CNS synapses. Neuron 26, 443455.
  • Hung A. Y., Futai K., Sala C. et al. (2008) Smaller dendritic spines, weaker synaptic transmission, but enhanced spatial learning in mice lacking Shank1. J. Neurosci. 28, 16971708.
  • Ide M. and Lewis D. A. (2010) Altered Cortical CDC42 Signaling Pathways in Schizophrenia: Implications for Dendritic Spine Deficits. Biol. Psychiatry 68, 2532.
  • Janssen M. J., Leiva-Salcedo E. and Buonanno A. (2012) Neuregulin directly decreases voltage-gated sodium current in hippocampal ErbB4-expressing interneurons. J. Neurosci. 32, 1388913895.
  • Jay T. M. (2003) Dopamine: a potential substrate for synaptic plasticity and memory mechanisms. Prog. Neurobiol. 69, 375390.
  • Kalus P., Bondzio J., Federspiel A., Muller T. J. and Zuschratter W. (2002) Cell-type specific alterations of cortical interneurons in schizophrenic patients. NeuroReport 13, 713717.
  • Kantrowitz J. T. and Javitt D. C. (2010) N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: the final common pathway on the road to schizophrenia? Brain Res. Bull. 83, 108121.
  • Kirkpatrick B., Xu L., Cascella N., Ozeki Y., Sawa A. and Roberts R. C. (2006) DISC1 immunoreactivity at the light and ultrastructural level in the human neocortex. J. Comp. Neurol. 497, 436450.
  • Kirov G., Pocklington A. J., Holmans P. et al. (2012) De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia. Mol. Psychiatry 17, 142153.
  • Koffie R. M., Meyer-Luehmann M., Hashimoto T. et al. (2009) Oligomeric amyloid beta associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques. Proc. Natl Acad. Sci. USA 106, 40124017.
  • Koffie R. M., Hyman B. T. and Spires-Jones T. L. (2011) Alzheimer's disease: synapses gone cold. Mol. Neurodegener. 6, 63.
  • Kolomeets N. S., Orlovskaya D. D., Rachmanova V. I. and Uranova N. A. (2005) Ultrastructural alterations in hippocampal mossy fiber synapses in schizophrenia: a postmortem morphometric study. Synapse 57, 4755.
  • Kolomeets N. S., Orlovskaya D. D. and Uranova N. A. (2007) Decreased numerical density of CA3 hippocampal mossy fiber synapses in schizophrenia. Synapse 61, 615621.
  • Kotrla K. J., Chacko R. C., Harper R. G., Jhingran S. and Doody R. (1995) SPECT findings on psychosis in Alzheimer's disease. Am. J. Psychiatry 152, 14701475.
  • Kvajo M., McKellar H., Arguello P. A., Drew L. J., Moore H., MacDermott A. B., Karayiorgou M. and Gogos J. A. (2008) A mutation in mouse Disc1 that models a schizophrenia risk allele leads to specific alterations in neuronal architecture and cognition. Proc. Natl Acad. Sci. USA 105, 70767081.
  • Kwon J. S., O'Donnell B. F., Wallenstein G. V., Greene R. W., Hirayasu Y., Nestor P. G., Hasselmo M. E., Potts G. F., Shenton M. E. and McCarley R. W. (1999) Gamma frequency-range abnormalities to auditory stimulation in schizophrenia. Arch. Gen. Psychiatry 56, 10011005.
  • Kwon O. B., Paredes D., Gonzalez C. M., Neddens J., Hernandez L., Vullhorst D. and Buonanno A. (2008) Neuregulin-1 regulates LTP at CA1 hippocampal synapses through activation of dopamine D4 receptors. Proc. Natl Acad. Sci. USA 105, 1558715592.
  • Lai C. and Lemke G. (1991) An extended family of protein-tyrosine kinase genes differentially expressed in the vertebrate nervous system. Neuron 6, 691704.
  • Laumonnier F., Cuthbert P. C. and Grant S. G. (2007) The role of neuronal complexes in human X-linked brain diseases. Am. J. Hum. Genet. 80, 205220.
  • Law A. J., Weickert C. S., Hyde T. M., Kleinman J. E. and Harrison P. J. (2004) Reduced spinophilin but not microtubule-associated protein 2 expression in the hippocampal formation in schizophrenia and mood disorders: molecular evidence for a pathology of dendritic spines. Am. J. Psychiatry 161, 18481855.
  • Law A. J., Kleinman J. E., Weinberger D. R. and Weickert C. S. (2007) Disease-associated intronic variants in the ErbB4 gene are related to altered ErbB4 splice-variant expression in the brain in schizophrenia. Hum. Mol. Genet. 16, 129141.
  • Lawrence J. J, Saraga F., Churchill J. F., Statland J. M., Travis K. E., Skinner F. K. and McBain C. J. (2006) Somatodendritic Kv7/KCNQ/M channels control interspike interval in hippocampal interneurons. J. Neurosci. 26, 1232512338.
  • Lewis D. A. and Gonzalez-Burgos G. (2008) Neuroplasticity of neocortical circuits in schizophrenia. Neuropsychopharmacology 33, 141165.
  • Lewis D. A. and Levitt P. (2002) Schizophrenia as a disorder of neurodevelopment. Annu. Rev. Neurosci. 25, 409432.
  • Lewis D. A., Hashimoto T. and Volk D. W. (2005) Cortical inhibitory neurons and schizophrenia. Nat. Rev. Neurosci. 6, 312324.
  • Li B., Woo R. S., Mei L. and Malinow R. (2007) The neuregulin-1 receptor erbB4 controls glutamatergic synapse maturation and plasticity. Neuron 54, 583597.
  • Li K. X., Lu Y. M., Xu Z. H. et al. (2012) Neuregulin 1 regulates excitability of fast-spiking neurons through Kv1.1 and acts in epilepsy. Nat. Neurosci. 15, 267273.
  • Lipska B. K., Peters T., Hyde T. M. et al. (2006) Expression of DISC1 binding partners is reduced in schizophrenia and associated with DISC1 SNPs. Hum. Mol. Genet. 15, 12451258.
  • Lisman J. E. and Grace A. A. (2005) The hippocampal-VTA loop: controlling the entry of information into long-term memory. Neuron 46, 703713.
  • Lisman J. E., Coyle J. T., Green R. W., Javitt D. C., Benes F. M., Heckers S. and Grace A. A. (2008) Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. Trends Neurosci. 31, 234242.
  • Longart M., Chatani-Hinze M., Gonzalez C. M., Vullhorst D. and Buonanno A. (2007) Regulation of ErbB-4 endocytosis by neuregulin in GABAergic hippocampal interneurons. Brain Res. Bull. 73, 210219.
  • Lue L. F., Kuo Y. M., Roher A. E., Brachova L., Shen Y., Sue L., Beach T., Kurth J. H., Rydel R. E. and Rogers J. (1999) Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am. J. Pathol. 155, 853862.
  • Ma X. M., Kiraly D. D., Gaier E. D., Wang Y., Kim E. J., Levine E. S., Eipper B. A. and Mains R. E. (2008) Kalirin-7 is required for synaptic structure and function. J. Neurosci. 28, 1236812382.
  • Matzner O. and Devor M. (1992) Na+ conductance and the threshold for repetitive neuronal firing. Brain Res. 597, 9298.
  • Mega M. S., Lee L., Dinov I. D., Mishkin F., Toga A. W. and Cummings J. L. (2000) Cerebral correlates of psychotic symptoms in Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 69, 167171.
  • Mei L. and Xiong W. C. (2008) Neuregulin 1 in neural development, synaptic plasticity and schizophrenia. Nat. Rev. Neurosci. 9, 437452.
  • Meier S., Demirakca T., Brusniak W. et al. (2012) SCN1A affects brain structure and the neural activity of the aging brain. Biol. Psychiatry 72, 677683.
  • Mentis M. J., Weinstein E. A., Horwitz B., McIntosh A. R., Pietrini P., Alexander G. E., Furey M. and Murphy D. G. (1995) Abnormal brain glucose metabolism in the delusional misidentification syndromes: a positron emission tomography study in Alzheimer disease. Biol. Psychiatry 38, 438449.
  • Meyer U. and Feldon J. (2009) Neural basis of psychosis-related behaviour in the infection model of schizophrenia. Behav. Brain Res. 204, 322334.
  • Milescu L. S., Yamanishi T., Ptak K. and Smith J. C. (2010) Kinetic properties and functional dynamics of sodium channels during repetitive spiking in a slow pacemaker neuron. J. Neurosci. 30, 1211312127.
  • Millar J. K., Christie S. and Porteous D. J. (2003) Yeast two-hybrid screens implicate DISC1 in brain development and function. Biochem. Biophys. Res. Commun. 311, 10191025.
  • Moessner R., Marshall C. R., Sutcliffe J. S. et al. (2007) Contribution of SHANK3 mutations to autism spectrum disorder. Am. J. Hum. Genet. 81, 12891297.
  • Mohn A. R., Gainetdinov R. R., Caron M. G. and Koller B. H. (1999) Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell 98, 427436.
  • Moran E. K., Becker J. A., Satlin A., Lyoo I. K., Fischman A. J. and Johnson K. A. (2008) Psychosis of Alzheimer's disease: Gender differences in regional perfusion. Neurobiol. Aging 29, 12181225.
  • Mukai J., Dhilla A., Drew L. J., Stark K. L., Cao L., MacDermott A. B., Karayiorgou M. and Gogos J. A. (2008) Palmitoylation-dependent neurodevelopmental deficits in a mouse model of 22q11 microdeletion. Nat. Neurosci. 11, 13021310.
  • Munafo M. R., Thiselton D. L., Clark T. G. and Flint J. (2006) Association of the NRG1 gene and schizophrenia: a meta-analysis. Mol. Psychiatry 11, 539546.
  • Munafo M. R., Attwood A. S. and Flint J. (2008) Neuregulin 1 genotype and schizophrenia. Schizophr. Bull. 34, 912.
  • Murray M. M., Bernstein S. L., Nyugen V., Condron M. M., Teplow D. B. and Bowers M. T. (2009) Amyloid beta protein: Abeta40 inhibits Abeta42 oligomerization. J. Am. Chem. Soc. 131, 63166317.
  • Murray P. S., Kirkwood C. M., Gray M. C. et al. (2012) beta-Amyloid 42/40 ratio and kalirin expression in Alzheimer disease with psychosis. Neurobiol. Aging 33, 28072816.
  • Murray P. S., Kirkwood C. M., Ikonomovic M. D., Fish K. N. and Sweet R. A. (2013) Tau phosphorylation is exaggerated in Alzheimer disease with psychosis. Am. J. Geriatr. Psychiatry. 21, S80S81.
  • Nadif Kasri N. and Van Aelst L. (2008) Rho-linked genes and neurological disorders. Pflugers Arch. 455, 787797.
  • Naslund J., Haroutunian V., Mohs R., Davis K. L., Davies P., Greengard P. and Buxbaum J. D. (2000) Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. JAMA 283, 15711577.
  • Neddens J. and Buonanno A. (2009) Selective populations of hippocampal interneurons express ErbB4 and their number and distribution is altered in ErbB4 knockout mice. Hippocampus 20, 724744.
  • Neddens J. and Buonanno A. (2011) Expression of the neuregulin receptor ErbB4 in the brain of the rhesus monkey (Macaca mulatta). PLoS ONE 6, e27337.
  • Neddens J., Fish K. N., Tricoire L., Vullhorst D., Shamir A., Chung W., Lewis D. A., McBain C. J. and Buonanno A. (2011) Conserved interneuron-specific ErbB4 expression in frontal cortex of rodents, monkeys, and humans: implications for schizophrenia. Biol. Psychiatry 70, 636645.
  • Nicodemus K. K., Law A. J., Radulescu E. et al. (2010) Biological validation of increased schizophrenia risk with NRG1, ERBB4, and AKT1 epistasis via functional neuroimaging in healthy controls. Arch. Gen. Psychiatry 67, 9911001.
  • Oblak A. L., Gibbs T. T. and Blatt G. J. (2010) Decreased GABA(B) receptors in the cingulate cortex and fusiform gyrus in autism. J. Neurochem. 114, 14141423.
  • O'Roak B. J. and State M. W. (2008) Autism genetics: strategies, challenges, and opportunities. Autism. Res. 1, 417.
  • Owen M. J., Craddock N. and O'Donovan M. C. (2005) Schizophrenia: genes at last? Trends Genet. 21, 518525.
  • Pavlowsky A., Gianfelice A., Pallotto M. et al. (2010) A postsynaptic signaling pathway that may account for the cognitive defect due to IL1RAPL1 mutation. Curr. Biol. 20, 103115.
  • Peça J., Feliciano C., Ting J. T., Wang W., Wells M. F., Venkatraman T. N., Lascola C. D., Fu Z. and Feng G. (2011) Shank3 mutant mice display autistic-like behaviours and striatal dysfunction. Nature 472, 437442.
  • Penzes P. and Jones K. A. (2008) Dendritic spine dynamics–a key role for kalirin-7. Trends Neurosci. 31, 419427.
  • Penzes P., Cahill M. E., Jones K. A. and Srivastava D. P. (2008) Convergent CaMK and RacGEF signals control dendritic structure and function. Trends Cell Biol. 18, 405413.
  • Penzes P., Cahill M. E., Jones K. A., VanLeeuwen J. E. and Woolfrey K. M. (2011) Dendritic spine pathology in neuropsychiatric disorders. Nat. Neurosci. 14, 285293.
  • Pinto D., Pagnamenta A. T., Klei L. et al. (2010) Functional impact of global rare copy number variation in autism spectrum disorders. Nature 466, 368372.
  • Piton A., Michaud J. L., Peng H. et al. (2008) Mutations in the calcium-related gene IL1RAPL1 are associated with autism. Hum. Mol. Genet. 17, 39653974.
  • Poot M., van der Smagt J. J., Brilstra E. H. and Bourgeron T. (2011) Disentangling the myriad genomics of complex disorders, specifically focusing on autism, epilepsy, and schizophrenia. Cytogenet. Genome Res. 135, 228240.
  • Powell A. D., Gill K. K., Saintot P. P., Jiruska P., Chelly J., Billuart P. and Jefferys J. G. (2012) Rapid reversal of impaired inhibitory and excitatory transmission but not spine dysgenesis in a mouse model of mental retardation. J. Physiol. 590, 763776.
  • Rakic P., Bourgeois J. P., Eckenhoff M. F., Zecevic N. and Goldman-Rakic P. S. (1986) Concurrent overproduction of synapses in diverse regions of the primate cerebral cortex. Science 232, 232235.
  • Rapoport J. L., Addington A. M., Frangou S. and Psych M. R. (2005) (2005) The neurodevelopmental model of schizophrenia: update. Mol. Psychiatry 10, 434449.
  • Rauch A., Hoyer J., Guth S. et al. (2006) Diagnostic yield of various genetic approaches in patients with unexplained developmental delay or mental retardation. Am. J. Med. Genet. A 140, 20632074.
  • Ropacki S. A. and Jeste D. V. (2005) Epidemiology of and risk factors for psychosis of Alzheimer's disease: a review of 55 studies published from 1990 to 2003. Am. J. Psychiatry 162, 20222030.
  • Ropers H. H. and Hamel B. C. (2005) X-linked mental retardation. Nat. Rev. Genet. 6, 4657.
  • Rosen A. M. and Stevens B. (2010) The role of the classical complement cascade in synapse loss during development and glaucoma. Adv. Exp. Med. Biol. 703, 7593.
  • Sato D., Lionel A. C., Leblond C. S. et al. (2012) SHANK1 Deletions in Males with Autism Spectrum Disorder. Am. J. Hum. Genet. 90, 879887.
  • Scheff S. W. and Price D. A. (2003) Synaptic pathology in Alzheimer's disease: a review of ultrastructural studies. Neurobiol. Aging 24, 10291046.
  • Schmeisser M. J., Ey E., Wegener S. et al. (2012) Autistic-like behaviours and hyperactivity in mice lacking ProSAP1/Shank2. Nature 486, 256260.
  • Schumacher J., Laje G., Abou Jamra R. et al. (2009) The DISC locus and schizophrenia: evidence from an association study in a central European sample and from a meta-analysis across different European populations. Hum. Mol. Genet. 18, 27192727.
  • Seeman P. (2009) Glutamate and dopamine components in schizophrenia. J. Psychiatry Neurosci. 34, 143149.
  • Selemon L. D. and Goldman-Rakic P. S. (1999) The reduced neuropil hypothesis: a circuit based model of schizophrenia. Biol. Psychiatry 45, 1725.
  • Selkoe D. J. (2002) Alzheimer's disease is a synaptic failure. Science 298, 789791.
  • Selkoe D. J. (2008) Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior. Behav. Brain Res. 192, 106113.
  • Shamir A., Kwon O. B., Karavanova I., Vullhorst D., Leiva-Salcedo E., Janssen M. J. and Buonanno A. (2012) The importance of the NRG-1/ErbB4 pathway for synaptic plasticity and behaviors associated with psychiatric disorders. J. Neurosci. 32, 29882997.
  • Shipton O. A., Leitz J. R., Dworzak J. et al. (2011) Tau protein is required for amyloid {beta}-induced impairment of hippocampal long-term potentiation. J. Neurosci. 31, 16881692.
  • Silberberg G., Darvasi A., Pinkas-Kramarski R. and Navon R. (2006) The involvement of ErbB4 with schizophrenia: association and expression studies. American journal of medical genetics. Part B, Neuropsychiatric genetics: the official publication of the International Society of. Psychiatr. Genet. 141B, 142148.
  • Spencer K. M. (2009) The functional consequences of cortical circuit abnormalities on gamma oscillations in schizophrenia: insights from computational modeling. Front. Hum. Neurosci. 3, 33.
  • Spencer K. M., Nestor P. G., Perlmutter R., Niznikiewicz M. A., Klump M. C., Frumin M., Shenton M. E. and McCarley R. W. (2004) Neural synchrony indexes disordered perception and cognition in schizophrenia. Proc. Natl Acad. Sci. USA 101, 1728817293.
  • Spires-Jones T. L., Meyer-Luehmann M., Osetek J. D., Jones P. B., Stern E. A., Bacskai B. J. and Hyman B. T. (2007) Impaired spine stability underlies plaque-related spine loss in an Alzheimer's disease mouse model. Am. J. Pathol. 171, 13041311.
  • van Spronsen M. and Hoogenraad C. C. (2010) Synapse pathology in psychiatric and neurologic disease. Curr. Neurol. Neurosci. Rep. 10, 207214.
  • Stark K. L., Xu B., Bagchi A. et al. (2008) Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11-deletion mouse model. Nat. Genet. 40, 751760.
  • Starkstein S. E., Vazquez S., Petracca G., Sabe L., Migliorelli R., Teson A. and Leiguarda R. (1994) A SPECT study of delusions in Alzheimer's disease. Neurology 44, 20552059.
  • Steen R. G., Mull C., McClure R., Hamer R. M. and Lieberman J. A. (2006) Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies. Br. J. Psychiatry 188, 510518.
  • Stefansson H., Sigurdsson E., Steinthorsdottir V. et al. (2002) Neuregulin 1 and Susceptibility to Schizophrenia. Am. J. Hum. Genet. 71.
  • Stefansson H., Thorgeirsson T. E., Gulcher J. R. and Stefansson K. (2003) Neuregulin 1 in schizophrenia: out of Iceland. Mol. Psychiatry 8, 639640.
  • Steiner H., Blum M., Kitai S. T. and Fedi P. (1999) Differential expression of ErbB3 and ErbB4 neuregulin receptors in dopamine neurons and forebrain areas of the adult rat. Exp. Neurol. 159, 494503.
  • Sultzer D. L., Brown C. V., Mandelkern M. A., Mahler M. E., Mendez M. F., Chen S. T. and Cummings J. L. (2003) Delusional thoughts and regional frontal/temporal cortex metabolism in Alzheimer's disease. Am. J. Psychiatry 160, 341349.
  • Sweet R. A., Nimgaonkar V. L., Devlin B., Lopez O. L. and DeKosky S. T. (2002a) Increased familial risk of the psychotic phenotype of Alzheimer disease. Neurology 58, 907911.
  • Sweet R. A., Panchalingam K., Pettegrew J. W., McClure R. J., Hamilton R. L., Lopez O. L., Kaufer D. I., DeKosky S. T. and Klunk W. E. (2002b) Psychosis in Alzheimer disease: postmortem magnetic resonance spectroscopy evidence of excess neuronal and membrane phospholipid pathology. Neurobiol. Aging 23, 547553.
  • Sweet R. A., Henteleff R. A., Zhang W., Sampson A. R. and Lewis D. A. (2009) Reduced dendritic spine density in auditory cortex of subjects with schizophrenia. Neuropsychopharmacology 34, 374389.
  • Sweet R. A., Bennett D. A., Graff-Radford N. R. and Mayeux R. (2010) Assessment and familial aggregation of psychosis in Alzheimer's disease from the National Institute on Aging Late Onset Alzheimer's Disease Family Study. Brain 133, 11551162.
  • Sweet R. A., Seltman H., Emanuel J. E., Lopez O. L., Becker J. T., Bis J. C., Weamer E. A., DeMichele-Sweet M. A. and Kuller L. H. (2012) Effect of Alzheimer's disease risk genes on trajectories of cognitive function in the Cardiovascular Health Study. Am. J. Psychiatry 169, 954962.
  • Tada T. and Sheng M. (2006) Molecular mechanisms of dendritic spine morphogenesis. Curr. Opin. Neurobiol. 16, 95101.
  • Tan W., Dean M. and Law A. J. (2010) Molecular cloning and characterization of the human ErbB4 gene: identification of novel splice isoforms in the developing and adult brain. PLoS ONE 5, e12924.
  • Terry R. D., Masliah E., Salmon D. P., Butters N., DeTeresa R., Hill R., Hansen L. A. and Katzman R. (1991) Physical basis of cognitive alterations in Alzheimer's disease: Synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 30, 572580.
  • Thompson M., Lauderdale S., Webster M. J., Chong V. Z., McClintock B., Saunders R. and Weickert C. S. (2007) Widespread expression of ErbB2, ErbB3 and ErbB4 in non-human primate brain. Brain Res. 1139, 95109.
  • Tukker J. J., Fuentealba P., Hartwich K., Somogyi P. and Klausberger T. (2007) Cell type-specific tuning of hippocampal interneuron firing during gamma oscillations in vivo. J. Neurosci. 27, 81848189.
  • Valnegri P., Khelfaoui M., Dorseuil O. et al. (2011a) A circadian clock in hippocampus is regulated by interaction between oligophrenin-1 and Rev-erbα. Nat. Neurosci. 14, 12931301.
  • Valnegri P., Montrasio C., Brambilla D., Ko J. W., Passafaro M. and Sala C. (2011b) The X-linked intellectual disability protein IL1RAPL1 regulates excitatory synapse formation by binding PTPδ and RhoGAP2. Hum. Mol. Genet. 20, 47974809.
  • Verpelli C., Dvoretskova E., Vicidomini C. et al. (2011) Importance of shank3 in regulating metabotropic glutamate receptor 5 (mGluR5) expression and signaling at synapses. J. Biol. Chem. 286, 3483934850.
  • Vullhorst D., Neddens J., Karavanova I., Tricoire L., Petralia R. S., McBain C. J. and Buonanno A. (2009) Selective expression of ErbB4 in interneurons, but not pyramidal cells, of the rodent hippocampus. J. Neurosci. 29, 1225512264.
  • Walsh D. M. and Selkoe D. J. (2007) A beta oligomers - a decade of discovery. J. Neurochem. 101, 11721184.
  • Walss-Bass C., Liu W., Lew D. F., Villegas R., Montero P., Dassori A., Leach R. J., Almasy L., Escamilla M. and Raventos H. (2006) A novel missense mutation in the transmembrane domain of neuregulin 1 is associated with schizophrenia. Biol. Psychiatry 60, 548553.
  • Wang X., McCoy P. A., Rodriguiz R. M. et al. (2011) Synaptic dysfunction and abnormal behaviors in mice lacking major isoforms of Shank3. Hum. Mol. Genet. 20, 30933108.
  • Weickert C. S., Tiwari Y., Schofield P. R., Mowry B. J. and Fullerton J. M. (2012) Schizophrenia-associated HapICE haplotype is associated with increased NRG1 type III expression and high nucleotide diversity. Transl. Psychiatry 2, e104.
  • Weissflog L., Scholz C. J., Jacob C. P. et al. (2012) KCNIP4 as a candidate gene for personality disorders and adult ADHD. Eur. Neuropsychopharmacol. S0924-977X, 00214-3.
  • Wen L., Lu Y. S., Zhu X. H. et al. (2010) Neuregulin 1 regulates pyramidal neuron activity via ErbB4 in parvalbumin-positive interneurons. Proc. Natl Acad. Sci. USA 107, 12111216.
  • Wilson H. L., Wong A. C., Shaw S. R., Tse W. Y., Stapleton G. A., Phelan M. C., Hu S., Marshall J. and McDermid H. E. (2003) Molecular characterisation of the 22q13 deletion syndrome supports the role of haploinsufficiency of SHANK3/PROSAP2 in the major neurological symptoms. J. Med. Genet. 40, 575584.
  • Wilson T. W., Hernandez O. O., Asherin R. M., Teale P. D., Reite M. L. and Rojas D. C. (2008) Cortical gamma generators suggest abnormal auditory circuitry in early-onset psychosis. Cereb. Cortex 18, 371378.
  • Winterer G. and Weinberger D. R. (2004) Genes, dopamine and cortical signal-to-noise ratio in schizophrenia. Trends Neurosci. 27, 683690.
  • Wöhr M., Roullet F. I., Hung A. Y., Sheng M. and Crawley J. N. (2011) Communication impairments in mice lacking Shank1: reduced levels of ultrasonic vocalizations and scent marking behavior. PLoS ONE 6, e20631.
  • Won H., Lee H. R., Gee H. Y. et al. (2012) Autistic-like social behaviour in Shank2-mutant mice improved by restoring NMDA receptor function. Nature 486, 261265.
  • Woo T. U., Whitehead R. E., Melchitzky D. S. and Lewis D. A. (1998) A subclass of prefrontal gamma-aminobutyric acid axon terminals are selectively altered in schizophrenia. Proc. Natl Acad. Sci. USA 95, 53415346.
  • Woo T. U., Walsh J. P. and Benes F. M. (2004) Density of glutamic acid decarboxylase 67 messenger RNA-containing neurons that express the N-methyl-D-aspartate receptor subunit NR2A in the anterior cingulate cortex in schizophrenia and bipolar disorder. Arch. Gen. Psychiatry 61, 649657.
  • Xie Z., Srivastava D. P., Photowala H., Kai L., Cahill M. E., Woolfrey K. M., Shum C. Y., Surmeier D. J. and Penzes P. (2007) Kalirin-7 controls activity-dependent structural and functional plasticity of dendritic spines. Neuron 56, 640656.
  • Xie Z., Cahill M. E. and Penzes P. (2010) Kalirin loss results in cortical morphological alterations. Mol. Cell. Neurosci. 43, 8189.
  • Yau H. J., Wang H. F., Lai C. and Liu F. C. (2003) Neural development of the neuregulin receptor ErbB4 in the cerebral cortex and the hippocampus: preferential expression by interneurons tangentially migrating from the ganglionic eminences. Cereb. Cortex 13, 252264.
  • Yip J., Soghomonian J. J. and Blatt G. J. (2007) Decreased GAD67 mRNA levels in cerebellar Purkinje cells in autism: pathophysiological implications. Acta Neuropathol. 113, 559568.
  • Yizhar O., Fenno L. E., Prigge M. et al. (2011) Neocortical excitation/inhibition balance in information processing and social dysfunction. Nature 477, 171178.
  • Yoshida T., Yasumura M., Uemura T., Lee S. J., Ra M., Taguchi R., Iwakura Y. and Mishina M. (2011) IL-1 Receptor Accessory Protein-Like 1 Associated with Mental Retardation and Autism Mediates Synapse Formation by Trans-Synaptic Interaction with Protein Tyrosine Phosphatase {delta}. J. Neurosci. 31, 1348513499.
  • Yu F. H., Mantegazza M., Westenbroek R. E., Robbins C. A., Kalume F., Burton K. A., Spain W. J., McKnight G. S., Scheuer T. and Catterall W. A. (2006) Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy. Nat. Neurosci. 9, 11421149.
  • Zemni R., Bienvenu T., Vinet M. C. et al. (2000) A new gene involved in X-linked mental retardation identified by analysis of an X;2 balanced translocation. Nat. Genet. 24, 167170.
  • Zempel H., Thies E., Mandelkow E. and Mandelkow E. M. (2010) Abeta oligomers cause localized Ca(2+) elevation, missorting of endogenous Tau into dendrites, Tau phosphorylation, and destruction of microtubules and spines. J. Neurosci. 30, 1193811950.
  • Zhao L., Ma Q. L., Calon F. et al. (2006) Role of p21-activated kinase pathway defects in the cognitive deficits of Alzheimer disease. Nat. Neurosci. 9, 234242.
  • Zuo Y., Lin A., Chang P. and Gan W. B. (2005) Development of long-term dendritic spine stability in diverse regions of cerebral cortex. Neuron 46, 181189.